|
Volumn 9, Issue 8, 2002, Pages 879-891
|
Vinorelbine in the treatment of non-small cell lung cancer
a a |
Author keywords
NSCLC; Review; Vinorelbine
|
Indexed keywords
AMIFOSTINE;
CARBOPLATIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOCETAXEL;
DRUG METABOLITE;
EPIRUBICIN;
ETOPOSIDE;
GEMCITABINE;
GRANULOCYTE COLONY STIMULATING FACTOR;
IFOSFAMIDE;
IRINOTECAN;
LONIDAMINE;
MESNA;
MITOMYCIN C;
NAVELBINE;
NITROSOUREA;
PACLITAXEL;
TAXANE DERIVATIVE;
VINBLASTINE;
VINCA ALKALOID;
VINCRISTINE;
VINDESINE;
ADVANCED CANCER;
ALOPECIA;
ANEMIA;
ANOREXIA;
BONE MARROW SUPPRESSION;
BONE MARROW TOXICITY;
CLINICAL TRIAL;
CONSTIPATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST BENEFIT ANALYSIS;
DIARRHEA;
DRUG HALF LIFE;
DRUG HYPERSENSITIVITY;
DRUG RESEARCH;
DRUG RESPONSE;
DRUG STRUCTURE;
ESOPHAGITIS;
FATALITY;
GASTROINTESTINAL TOXICITY;
GRANULOCYTOPENIA;
HUMAN;
LUNG NON SMALL CELL CANCER;
METASTASIS;
MOUSE;
NAUSEA AND VOMITING;
NEPHROTOXICITY;
NEUROPATHY;
NEUROTOXICITY;
NEUTROPENIA;
NONHUMAN;
PARALYTIC ILEUS;
QUALITY OF LIFE;
REVIEW;
STANDARD;
STOMATITIS;
SYMPTOMATOLOGY;
|
EID: 0036250031
PISSN: 09298673
EISSN: None
Source Type: Journal
DOI: 10.2174/0929867024606777 Document Type: Review |
Times cited : (7)
|
References (156)
|